Human induced pluripotent stem cell–derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes

I Karakikes, M Ameen, V Termglinchan… - Circulation research, 2015 - Am Heart Assoc
Disease models are essential for understanding cardiovascular disease pathogenesis and
developing new therapeutics. The human induced pluripotent stem cell (iPSC) technology …

An overview of injectable polymeric hydrogels for tissue engineering

A Sivashanmugam, RA Kumar, MV Priya… - European Polymer …, 2015 - Elsevier
The desire and need to minimize traditional open surgeries is gearing up as it could reduce
the healthcare expenses and improve the recovery time for the patients. Minimal invasive …

Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts

Y Shiba, T Gomibuchi, T Seto, Y Wada, H Ichimura… - Nature, 2016 - nature.com
Induced pluripotent stem cells (iPSCs) constitute a potential source of autologous patient-
specific cardiomyocytes for cardiac repair, providing a major benefit over other sources of …

Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues

IY Shadrin, BW Allen, Y Qian, CP Jackman… - Nature …, 2017 - nature.com
Despite increased use of human induced pluripotent stem cell-derived cardiomyocytes
(hiPSC-CMs) for drug development and disease modeling studies, methods to generate …

Chemically defined generation of human cardiomyocytes

PW Burridge, E Matsa, P Shukla, ZC Lin, JM Churko… - Nature …, 2014 - nature.com
Existing methods for human induced pluripotent stem cell (hiPSC) cardiac differentiation are
efficient but require complex, undefined medium constituents that hinder further elucidation …

Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions

X Lian, J Zhang, SM Azarin, K Zhu, LB Hazeltine… - Nature protocols, 2013 - nature.com
The protocol described here efficiently directs human pluripotent stem cells (hPSCs) to
functional cardiomyocytes in a completely defined, growth factor–and serum-free system by …

Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction

SJ Park, RY Kim, BW Park, S Lee, SW Choi… - Nature …, 2019 - nature.com
Since both myocardium and vasculature in the heart are excessively damaged following
myocardial infarction (MI), therapeutic strategies for treating MI hearts should concurrently …

Conversion of human fibroblasts into functional cardiomyocytes by small molecules

N Cao, Y Huang, J Zheng, CI Spencer, Y Zhang, JD Fu… - Science, 2016 - science.org
Reprogramming somatic fibroblasts into alternative lineages would provide a promising
source of cells for regenerative therapy. However, transdifferentiating human cells into …

Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells

L Ye, YH Chang, Q Xiong, P Zhang, L Zhang… - Cell stem cell, 2014 - cell.com
Human induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following
injury, but preclinical studies in large animal models are required to determine optimal cell …

Cyclin D2 overexpression enhances the efficacy of human induced pluripotent stem cell–derived cardiomyocytes for myocardial repair in a swine model of myocardial …

M Zhao, Y Nakada, Y Wei, W Bian, Y Chu… - Circulation, 2021 - Am Heart Assoc
Background: Human induced pluripotent stem cells with normal (wild-type) or upregulated
(overexpressed) levels of CCND2 (cyclin D2) expression were differentiated into …